Muscular Dystrophy Association Launches New Venture Philanthropy
Will Apply VC Business Practices to Funding Research
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
In the newly emerging realm of venture philanthropy, MVP will be uniquely positioned because of its ability to build upon MDA's highly successful translational research program that efficiently integrates the various steps in research and clinical trials, while leveraging MDA's significant clinical resources.
0 Comments
View Comments
Related Content
Comments